Identification of cellular microRNA miR-188-3p with broad-spectrum anti-influenza A virus activity
Abstract Background Influenza A virus (IAV) continues to pose serious threats to public health. The current prophylaxis and therapeutic interventions for IAV requires frequent changes due to the continuous antigenic drift and antigenic shift of IAV. Emerging evidence indicates that the host microRNA...
Main Authors: | Huan Cui, Chunmao Zhang, Zongzheng Zhao, Cheng Zhang, Yingying Fu, Jiaming Li, Guanxi Chen, Mengxi Lai, Zhixiang Li, Shishan Dong, Ligong Chen, Zhaoyang Li, Chengyu Wang, Juxiang Liu, Yuwei Gao, Zhendong Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Virology Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12985-020-1283-9 |
Similar Items
-
Broad-spectrum antiviral agents
by: Jun-Da eZhu, et al.
Published: (2015-05-01) -
Broad-Spectrum Antiviral Strategies and Nucleoside Analogues
by: Robert J. Geraghty, et al.
Published: (2021-04-01) -
Potential Antiviral Options against SARS-CoV-2 Infection
by: Aleksandr Ianevski, et al.
Published: (2020-06-01) -
Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral
by: Yanmei Hu, et al.
Published: (2017-09-01) -
Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral
by: Hu, Yanmei, et al.
Published: (2017)